tracking
Rate this Video

Ischemic Stroke: Can a Biomarker Predict Which Patients Will Benefit From Different Therapies?

From the 2013 AAN Annual Meeting: Can a biomarker predict which ischemic stroke patients benefit from anticoagulants or antiplatelet agents? In a video interview, Neurology Today's Editor-in-Chief Steven P. Ringel, MD, and Associate Editor Robert Holloway, MD, discuss the key clinical takeaways from the latest analysis of data from the Antiphospholipid Antibodies and Stroke Study and the Warfarin-Aspirin Recurrent Stroke Study. The full story here: http://bit.ly/1cZcek5
Link
Embed
Email
Comments (0)
Add your comment
Advertisement